Nouveau Life Pharmaceuticals Inc (NOUV)

[Avispa]

OTC SECURITY DETAILS (TICKER-SP-OS-MC-STATUS)

KALY – 0.0066 – 1b – 6,600,000 - STOP
NOUV – 0.0004 – 10b – 4,000,000 – STOP
PURA – 0.096 – 500m – 48,000,000 – CURRENT
USMJ – 0.0004 – 20b – 8,000,000 – CURRENT

Conclusions: KALY undervalued compared to PURA. NOUV should at least double its SP. Imagine the effect on SP once they becomes current.